UniProt ID | TYDP1_HUMAN | |
---|---|---|
UniProt AC | Q9NUW8 | |
Protein Name | Tyrosyl-DNA phosphodiesterase 1 | |
Gene Name | TDP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 608 | |
Subcellular Localization | Nucleus . Cytoplasm . | |
Protein Description | DNA repair enzyme that can remove a variety of covalent adducts from DNA through hydrolysis of a 3'-phosphodiester bond, giving rise to DNA with a free 3' phosphate. Catalyzes the hydrolysis of dead-end complexes between DNA and the topoisomerase I active site tyrosine residue. Hydrolyzes 3'-phosphoglycolates on protruding 3' ends on DNA double-strand breaks due to DNA damage by radiation and free radicals. Acts on blunt-ended double-strand DNA breaks and on single-stranded DNA. Has low 3'exonuclease activity and can remove a single nucleoside from the 3'end of DNA and RNA molecules with 3'hydroxyl groups. Has no exonuclease activity towards DNA or RNA with a 3'phosphate.. | |
Protein Sequence | MSQEGDYGRWTISSSDESEEEKPKPDKPSTSSLLCARQGAANEPRYTCSEAQKAAHKRKISPVKFSNTDSVLPPKRQKSGSQEDLGWCLSSSDDELQPEMPQKQAEKVVIKKEKDISAPNDGTAQRTENHGAPACHRLKEEEDEYETSGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSQEGDYGR ------CCCCCCCCC | 36.62 | 30177828 | |
11 | Phosphorylation | EGDYGRWTISSSDES CCCCCCEEECCCCCC | 15.04 | 21406692 | |
13 | Phosphorylation | DYGRWTISSSDESEE CCCCEEECCCCCCCC | 19.20 | 17081983 | |
14 | Phosphorylation | YGRWTISSSDESEEE CCCEEECCCCCCCCC | 37.65 | 25159151 | |
15 | Phosphorylation | GRWTISSSDESEEEK CCEEECCCCCCCCCC | 38.31 | 19276368 | |
18 | Phosphorylation | TISSSDESEEEKPKP EECCCCCCCCCCCCC | 56.13 | 30108239 | |
22 | Sumoylation | SDESEEEKPKPDKPS CCCCCCCCCCCCCCC | 62.72 | - | |
22 | Sumoylation | SDESEEEKPKPDKPS CCCCCCCCCCCCCCC | 62.72 | - | |
29 | Phosphorylation | KPKPDKPSTSSLLCA CCCCCCCCHHHHHHH | 46.81 | 27080861 | |
30 | Phosphorylation | PKPDKPSTSSLLCAR CCCCCCCHHHHHHHH | 30.75 | 30108239 | |
31 | Phosphorylation | KPDKPSTSSLLCARQ CCCCCCHHHHHHHHC | 24.27 | 27080861 | |
32 | Phosphorylation | PDKPSTSSLLCARQG CCCCCHHHHHHHHCC | 26.00 | 27080861 | |
53 | Ubiquitination | YTCSEAQKAAHKRKI CCHHHHHHHHHHCCC | 55.37 | - | |
61 | Phosphorylation | AAHKRKISPVKFSNT HHHHCCCCCCCCCCC | 27.03 | 30278072 | |
66 | Phosphorylation | KISPVKFSNTDSVLP CCCCCCCCCCCCCCC | 32.86 | 29214152 | |
68 | Phosphorylation | SPVKFSNTDSVLPPK CCCCCCCCCCCCCCC | 28.58 | 30108239 | |
70 | Phosphorylation | VKFSNTDSVLPPKRQ CCCCCCCCCCCCCCC | 24.42 | 29214152 | |
79 | Phosphorylation | LPPKRQKSGSQEDLG CCCCCCCCCCHHHHH | 35.03 | 20873877 | |
81 | Phosphorylation | PKRQKSGSQEDLGWC CCCCCCCCHHHHHHH | 37.17 | 23663014 | |
90 | Phosphorylation | EDLGWCLSSSDDELQ HHHHHHHCCCCCCCC | 25.35 | 23663014 | |
91 | Phosphorylation | DLGWCLSSSDDELQP HHHHHHCCCCCCCCC | 25.49 | 23663014 | |
92 | Phosphorylation | LGWCLSSSDDELQPE HHHHHCCCCCCCCCC | 45.78 | 28102081 | |
107 | Acetylation | MPQKQAEKVVIKKEK CCHHHHHEEEEEECC | 44.83 | 25953088 | |
112 | Sumoylation | AEKVVIKKEKDISAP HHEEEEEECCCCCCC | 59.89 | - | |
114 | Acetylation | KVVIKKEKDISAPND EEEEEECCCCCCCCC | 70.06 | 25953088 | |
114 | Ubiquitination | KVVIKKEKDISAPND EEEEEECCCCCCCCC | 70.06 | - | |
139 | Sumoylation | APACHRLKEEEDEYE CCCCCCCCCHHCCCC | 64.14 | - | |
139 | Ubiquitination | APACHRLKEEEDEYE CCCCCCCCCHHCCCC | 64.14 | 21906983 | |
139 | Sumoylation | APACHRLKEEEDEYE CCCCCCCCCHHCCCC | 64.14 | - | |
145 | Phosphorylation | LKEEEDEYETSGEGQ CCCHHCCCCCCCCCC | 36.51 | 28796482 | |
147 | Phosphorylation | EEEDEYETSGEGQDI CHHCCCCCCCCCCCH | 40.92 | 22617229 | |
148 | Phosphorylation | EEDEYETSGEGQDIW HHCCCCCCCCCCCHH | 23.94 | 22617229 | |
169 | Phosphorylation | NPFQFYLTRVSGVKP CCCEEEEEEECCCCC | 20.04 | 28555341 | |
169 | O-linked_Glycosylation | NPFQFYLTRVSGVKP CCCEEEEEEECCCCC | 20.04 | 30379171 | |
172 | O-linked_Glycosylation | QFYLTRVSGVKPKYN EEEEEEECCCCCCCC | 34.28 | 30379171 | |
175 | Acetylation | LTRVSGVKPKYNSGA EEEECCCCCCCCCCC | 39.04 | 25953088 | |
177 | Acetylation | RVSGVKPKYNSGALH EECCCCCCCCCCCCC | 51.88 | 25953088 | |
222 | Ubiquitination | YPPEFRKKPILLVHG CCHHHHCCCEEEEEC | 32.79 | - | |
231 | Ubiquitination | ILLVHGDKREAKAHL EEEEECCHHHHHHHH | 57.65 | - | |
243 | Ubiquitination | AHLHAQAKPYENISL HHHHCCCCCCCCCCC | 35.73 | - | |
311 | Ubiquitination | RIADGTHKSGESPTH EECCCCCCCCCCCCC | 61.05 | - | |
334 | Phosphorylation | LMAYNAPSLKEWIDV HHHHCCCCHHHHHHH | 50.06 | - | |
365 | Phosphorylation | TPGRFQGSQKDNWGH CCCCCCCCCCCCCHH | 24.23 | 17478428 | |
367 | Ubiquitination | GRFQGSQKDNWGHFR CCCCCCCCCCCHHHH | 55.51 | - | |
417 | Acetylation | KWLCSEFKESMLTLG HHHHHHHHHHHHHCC | 44.84 | 25953088 | |
417 | Ubiquitination | KWLCSEFKESMLTLG HHHHHHHHHHHHHCC | 44.84 | - | |
427 | Phosphorylation | MLTLGKESKTPGKSS HHHCCCCCCCCCCCC | 45.36 | 21712546 | |
429 | Phosphorylation | TLGKESKTPGKSSVP HCCCCCCCCCCCCCC | 46.70 | 21712546 | |
432 | Ubiquitination | KESKTPGKSSVPLYL CCCCCCCCCCCCEEE | 40.54 | - | |
434 | Phosphorylation | SKTPGKSSVPLYLIY CCCCCCCCCCEEEEC | 31.10 | 21712546 | |
459 | Phosphorylation | EGYPAGGSLPYSIQT CCCCCCCCCCCCCHH | 25.83 | 19690332 | |
466 | Phosphorylation | SLPYSIQTAEKQNWL CCCCCCHHHHHCCCH | 34.80 | 19690332 | |
469 | Ubiquitination | YSIQTAEKQNWLHSY CCCHHHHHCCCHHHH | 46.60 | - | |
518 | Phosphorylation | LVTSANLSKAAWGAL HHHHCCCCHHHHHHH | 21.76 | 18452278 | |
563 | Phosphorylation | KQKFFAGSQEPMATF ECCCCCCCCCCCEEC | 28.13 | 28464451 | |
569 | Phosphorylation | GSQEPMATFPVPYDL CCCCCCEECCCCCCC | 23.40 | 22199227 | |
581 | Phosphorylation | YDLPPELYGSKDRPW CCCCHHHCCCCCCCE | 20.07 | 22199227 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TYDP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TYDP1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
VAMP2_HUMAN | VAMP2 | physical | 22939629 | |
NU153_HUMAN | NUP153 | physical | 26186194 | |
TERA_HUMAN | VCP | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy (SCAN1) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-147 AND SER-148, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-61, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-11; SER-13; SER-14 ANDSER-15, AND MASS SPECTROMETRY. |